Phase II, Randomized, Placebo-controlled, 90-day Study of Emixustat HCL in Geographic Atrophy Associated with Dry Age-Related Macular Degeneration

PURPOSE: This study assessed the safety, tolerability, and pharmacodynamics of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD). METHODS: Subjects were randomly assigned to oral emi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Retina
Päätekijät: Dugel, Pravin U., Novack, Roger L., Csaky, Karl G., Richmond, Preston P., Birch, David G., Kubota, Ryo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452434/
https://ncbi.nlm.nih.gov/pubmed/25932553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000000606
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia